OnKure Therapeutics, Inc. OKUR Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by OnKure Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about OnKure Therapeutics, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OnKure Therapeutics, Inc.'s accounts payable?
- OnKure Therapeutics, Inc. (OKUR) reported accounts payable of $11.02M in Q1 2026.
- How has OnKure Therapeutics, Inc.'s accounts payable changed year-over-year?
- OnKure Therapeutics, Inc.'s accounts payable increased by 370.2% year-over-year, from $2.34M to $11.02M.
- What is the long-term trend for OnKure Therapeutics, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), OnKure Therapeutics, Inc.'s accounts payable has grown at a 9.6% compound annual growth rate (CAGR), from $908K to $1.43M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.